These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 90755)

  • 1. Metabolism and action of steroid hormones on human benign prostatic hyperplasia and prostatic carcinoma grown in organ culture.
    Lasnitzki I
    J Steroid Biochem; 1979 Jul; 11(1B):625-30. PubMed ID: 90755
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
    Bard DR; Lasnitzki I
    J Endocrinol; 1977 Jul; 74(1):1-9. PubMed ID: 68984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign hyperplasia of the human prostate exposed to steroid hormones in organ culture.
    Harbitz TB; Falkanger B; Sander S
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():89-93. PubMed ID: 4141577
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of steroid hormones on the growth pattern and RNA synthesis in human benign prostatic hyperplasia in organ culture.
    Lasnitzki I; Whitaker RH; Withycombe JF
    Br J Cancer; 1975 Aug; 32(2):168-78. PubMed ID: 55269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
    Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758
    [No Abstract]   [Full Text] [Related]  

  • 6. Human prostatic carcinoma: significant differences in its androgen binding and metabolism compared to the human benign prostatic hypertrophy.
    Krieg M; Grobe I; Voight KD; Altenähr E; Klosterhalfen H
    Acta Endocrinol (Copenh); 1978 Jun; 88(2):397-407. PubMed ID: 78653
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
    Baranowska B; Zgliczyński S
    Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
    Gloyna RE; Siiteri PK; Wilson JD
    J Clin Invest; 1970 Sep; 49(9):1746-53. PubMed ID: 4194769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R; Puah CM
    J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C19O2-Steroid transformations in the human normal, hyperplastic and cancerous prostate.
    Morfin RF; Charles JF; Floch HH
    J Steroid Biochem; 1979 Jul; 11(1B):599-607. PubMed ID: 90752
    [No Abstract]   [Full Text] [Related]  

  • 11. The action of hormone metabolites: a new concept in endocrinology (on the metabolism and the activity of testosterone).
    Baulieu EE
    Rev Eur Etud Clin Biol; 1970; 15(7):723-6. PubMed ID: 4097682
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of oestradiol-17beta and progesterone on the metabolism of testosterone by human prostatic tissue.
    Jenkins JS; McCaffery VM
    J Endocrinol; 1974 Dec; 63(3):517-26. PubMed ID: 4141718
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
    BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
    Isaacs JT; Coffey DS
    Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered androgen metabolism in carcinoma of the prostate.
    Ghanadian R; Masters JR; Smith CB
    Eur Urol; 1981; 7(3):169-70. PubMed ID: 6162644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen metabolism in the hypertrophic prostate.
    Wilson JD; Gloyna RE; Siiteri PK
    J Steroid Biochem; 1975; 6(3-4):443-5. PubMed ID: 52762
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
    Krieg M; Bartsch W; Janssen W; Voigt KD
    J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
    [No Abstract]   [Full Text] [Related]  

  • 18. Testosterone 5 alpha-reductase and the accumulation of dihydrotestosterone in benign prostatic hyperplasia.
    Cowan RA; Cook B; Cowan SK; Grant JK; Sirett DA; Wallace AM
    J Steroid Biochem; 1979 Jul; 11(1B):609-13. PubMed ID: 90753
    [No Abstract]   [Full Text] [Related]  

  • 19. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is the prostatic adenoma of hormonal origin].
    Bercovici JP; Morfin R; Charles JF
    Nouv Presse Med; 1975 Feb; 4(7):475-8. PubMed ID: 48234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.